EGFR and cancer: It has been also hypothesized that the oncogenic variant of the epidermal growth factor receptor (EGFR), a well-known proto-oncogene widely overexpressed and/or amplified in human cancer [15, 16], may be correlated with CBX3 expression in NSCLC [8].